Marker Therapeutics to Host Clinical Program Update Conference Call and Webcast on Wednesday, February 16, 2022
The webcast will be accessible in the Investors section of the Company's website at www.markertherapeutics.com. Individuals can participate in the conference call by dialing 877-869-3847 (domestic) or 201-689-8261 (international) and referring to the "Marker Therapeutics Clinical Program Update Call."
The archived webcast will be available for replay on the Marker website following the event.
To receive future press releases via email, please visit: https://www.markertherapeutics.com/email-alerts.
IR and Media Contacts
Vice President/Head of Investor Relations, PR & Marketing
Source: Marker Therapeutics